Free Trial
NASDAQ:ECOR

electroCore (ECOR) Stock Price, News & Analysis

$6.18
+0.18 (+3.00%)
(As of 09/6/2024 ET)
Today's Range
$5.94
$6.22
50-Day Range
$5.65
$6.43
52-Week Range
$4.90
$8.08
Volume
46,974 shs
Average Volume
11,237 shs
Market Capitalization
$37.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

electroCore MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.55mentions of electroCore in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$37,030 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.32) to ($0.37) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.63 out of 5 stars

Medical Sector

794th out of 909 stocks

Electromedical Equipment Industry

21st out of 23 stocks

ECOR stock logo

About electroCore Stock (NASDAQ:ECOR)

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

ECOR Stock Price History

ECOR Stock News Headlines

Here’s A Painful Truth and 100% Fact About The Stocks You’re Holding
Charles Payne here, and I want to let you in on an uncomfortable truth that long term investors and retirees need to hear. It's shocking to me that more people aren't wise to this, as they are leaving money on the table from stocks they have a strong belief in. I call it "The Cash Flow Trade", and my team is going to teach you how and when to execute it in this free live event.
Here’s A Painful Truth and 100% Fact About The Stocks You’re Holding
Charles Payne here, and I want to let you in on an uncomfortable truth that long term investors and retirees need to hear. It's shocking to me that more people aren't wise to this, as they are leaving money on the table from stocks they have a strong belief in. I call it "The Cash Flow Trade", and my team is going to teach you how and when to execute it in this free live event.
See More Headlines
Receive ECOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for electroCore and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/07/2024
Today
9/06/2024
Next Earnings (Estimated)
11/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ECOR
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Net Income
$-18,830,000.00
Pretax Margin
-67.30%

Debt

Sales & Book Value

Annual Sales
$21.28 million
Book Value
$1.78 per share

Miscellaneous

Free Float
5,217,000
Market Cap
$37.12 million
Optionable
Not Optionable
Beta
0.62
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Daniel S. GoldbergerMr. Daniel S. Goldberger (Age 65)
    CEO & Director
    Comp: $1.05M
  • Dr. Thomas J. Errico M.D. (Age 72)
    Founder, Independent Director & Principal Investor
    Comp: $58.12k
  • Mr. Brian M. Posner CPAMr. Brian M. Posner CPA (Age 62)
    MBA., CFO & Corporate Secretary
    Comp: $599.88k
  • Mr. Michael Romaniw (Age 67)
    Executive Vice President of Systems & Operations
  • Mr. Donald Melnikoff
    Senior Vice President of Engineering, Regulatory & Compliance
  • Mr. Mitch Deshon
    Vice President of Global Sales & Business Development
  • Ms. Carrie Kochek
    Senior Director of Human Resources
  • Dr. Peter S. Staats M.B.A. (Age 60)
    M.D., Chief Medical Officer
    Comp: $238.41k
  • Mr. Joshua S. Lev
    Chief Strategy Officer
  • Mr. Manuel A. Marques (Age 51)
    Senior Vice President of Operations

ECOR Stock Analysis - Frequently Asked Questions

How have ECOR shares performed this year?

electroCore's stock was trading at $5.95 at the start of the year. Since then, ECOR stock has increased by 3.9% and is now trading at $6.18.
View the best growth stocks for 2024 here
.

How were electroCore's earnings last quarter?

electroCore, Inc. (NASDAQ:ECOR) posted its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.39) by $0.01. The company earned $6.14 million during the quarter, compared to analysts' expectations of $5.85 million. electroCore had a negative trailing twelve-month return on equity of 165.17% and a negative net margin of 66.84%.

When did electroCore's stock split?

electroCore's stock reverse split on Tuesday, February 14th 2023. The 1-15 reverse split was announced on Tuesday, February 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did electroCore IPO?

electroCore (ECOR) raised $64 million in an IPO on Friday, June 22nd 2018. The company issued 4,300,000 shares at $14.00-$16.00 per share. Evercore ISI and JMP Securities acted as the underwriters for the IPO and BTIG was co-manager.

Who are electroCore's major shareholders?

electroCore's top institutional shareholders include Renaissance Technologies LLC (1.15%) and International Assets Investment Management LLC (1.05%). Insiders that own company stock include Daniel S Goldberger, Thomas J Errico, Joseph P Errico, John P Gandolfo, Trevor J Moody and Brian M Posner.
View institutional ownership trends
.

How do I buy shares of electroCore?

Shares of ECOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of electroCore own?

Based on aggregate information from My MarketBeat watchlists, some other companies that electroCore investors own include T2 Biosystems (TTOO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Bionano Genomics (BNGO) and Matinas BioPharma (MTNB).

This page (NASDAQ:ECOR) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners